Hepatitis, Alcoholic
7
0
0
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
14.3%
1 terminated out of 7 trials
66.7%
-19.8% vs benchmark
14%
1 trials in Phase 3/4
100%
2 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Cohort/Ethics Study of Patients With Severe Alcoholic Hepatitis Undergoing Early Liver Transplantation
A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area
Safety and Efficacy of IMM 124-E for Patients With Severe Alcoholic Hepatitis
Alcoholic Hepatitis in Latin-America: A Prospective and Multicentric Study (AH-LATIN).
Alcohol Diet and Drug Use Preceding Alcoholic Hepatitis
Efficacy and Safety of S-adenosyl-l-methionine in Treatment of Alcoholic Hepatitis With Cholestasis
Pentoxifylline for Acute Alcoholic Hepatitis (AAH)